Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER-2 Positive Malignant Carcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT06868017
What this trial is testing

Randomized Controlled Clinical Study of Efficacy and Safety of Initumab Combined with Pyrrotinib and Chemotherapeutic Agents in Neoadjuvant Therapy for HER2-positive Breast Cancer with Different Treatment Cycles

Who this might be right for
HER2 Positive Breast Cancer
The First Hospital of Jilin University 208
Early research (Phase 1)Study completedNCT03841110
What this trial is testing

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsLymphomaGastric Cancer+15 more
Fate Therapeutics 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT02326974
What this trial is testing

T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA

Who this might be right for
HER-2 Positive Breast CancerBreast CancerStage II Breast Cancer+1 more
Dana-Farber Cancer Institute 164
Testing effectiveness (Phase 2)Ended earlyNCT00079326
What this trial is testing

Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast CancerRecurrent Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Study completedNCT02362958
What this trial is testing

A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer

Who this might be right for
HER2 Positive Breast Cancer
Sun Yat-sen University 159
Testing effectiveness (Phase 2)Study completedNCT01242449
What this trial is testing

Oral Vinorelbine in Combination With Trastuzumab for Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Vejle Hospital 10
Large-scale testing (Phase 3)Study completedNCT00670878
What this trial is testing

Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
Ludwig-Maximilians - University of Munich 799
Large-scale testing (Phase 3)Study completedNCT01998906
What this trial is testing

Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 330
Testing effectiveness (Phase 2)Looking for participantsNCT05748834
What this trial is testing

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 36
Early research (Phase 1)Study completedNCT01602406
What this trial is testing

Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer

Who this might be right for
Advanced HER2-positive Breast Cancer or Gastric Cancer
Novartis Pharmaceuticals 64
Testing effectiveness (Phase 2)Study completedNCT01853748
What this trial is testing

T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 512
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07528898
What this trial is testing

Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study.

Who this might be right for
Breast Cancer
Hebei Medical University Fourth Hospital 100
Not applicableEnded earlyNCT02963363
What this trial is testing

Adapted Physical Activity for Breast Cancer HER2 Positive Patient

Who this might be right for
HER2 Positive Breast Cancer
Centre Jean Perrin 36
Not applicableUnknownNCT01424865
What this trial is testing

Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,874
Testing effectiveness (Phase 2)Study completedNCT01196052
What this trial is testing

Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 153
Testing effectiveness (Phase 2)Ended earlyNCT03367676
What this trial is testing

12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER)

Who this might be right for
Breast Cancer
Ruijin Hospital 78
Early research (Phase 1)Study completedNCT01148849
What this trial is testing

Safety Study of MGAH22 in HER2-positive Carcinomas

Who this might be right for
Breast CancerGastric Cancer
MacroGenics 66
Testing effectiveness (Phase 2)Looking for participantsNCT04893109
What this trial is testing

ATEMPT 2.0: Adjuvant T-DM1 vs TH

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Dana-Farber Cancer Institute 500
Early research (Phase 1)Looking for participantsNCT07137416
What this trial is testing

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Carcinoma+13 more
National Cancer Institute (NCI) 36
Not applicableActive Not RecruitingNCT05889988
What this trial is testing

Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients

Who this might be right for
Breast Neoplasm
Mayo Clinic 36
Next Page